Skip to Content

Swine flu attracts online scammers, flooding US market with fake pills

Text SizeAAA

Filed under: Technology, Economy, Healthcare

More

Standing on the threshold of what looks to be a long, cold winter, many people are already preparing to fight the onslaught of the H1N1 virus, also knows as swine flu, avian flu, Spanish flu or plain old influenza. In addition to standard Centers for Disease Control–endorsed preventatives (getting enough sleep, washing hands), some consumers are looking into oseltamavir-based anti-flu drugs like Gilead Sciences (GILD)'s pill Tamiflu.

The trouble is, it's impossible to get oseltamavir in the U.S. without a prescription, so people who are out of work, dealing with health-insurance red tape, or trying to save money may have a hard time buying the drug. For those consumers, online pharmacies based outside the U.S. hold the promise of cheap, convenient access to a proven flu killer.

In some cases, online pharmacies have been selling drugs for up to 90 percent off retail -- but at these prices, the pills may offer much less than they promise. "When a pill is selling for 10 percent of the retail price, you know it didn't come through a standard distribution network," says Fred Felman, chief marketing director of MarkMonitor. "It's probably fake, expired, or an offshore generic that wasn't inspected by the Food and Drug Administration."

In an investigation of mail-order oseltamavir drugs, the FDA noted that the pills often took too long to arrive, had inconsistent dosages, and sometimes didn't even contain oseltamavir. One shipment contained pills composed of acetaminophen and talcum powder.

Not all off-brand drugs are placebos: many disreputable drug manufacturers also purchase bulk quantities of active pharmaceutical ingredients and produce their own pills. While these capsules often contain the active ingredient that they claim, their production facilities are not as controlled as those of mainstream pharmaceutical companies; some, Felman says, have "work benches covered in dust and dirt, and use cement mixers to coat and polish their tablets."

With fear over swine flu reaching a fever pitch and health insurance more pricey than ever, online pharmacies are huge. Business-to-business sales of active pharmaceutical ingredients have risen 23 percent this year and, according to MarkMonitor estimates, online pharmacies are generating $10.7 billion in revenue, up from roughly $4 billion in 2007. While 49 percent of these pharmacies were based in China, the operations are global: a North American phone number connects to a Russian-accented operator selling drugs shipped from India and billing the buyer's credit card through Israel.

This isn't to say that all online pharmacies are scams. One site, LegitScript, certifies online pharmacies' legitimacy. Particularly vigilant users can visit the Web sites of the Canadian International Pharmacy Association or the Verified Internet Pharmacy Practice Site to ensure that a particular pharmacy is accredited.

Reader Comments (Page 1 of 1)

Add your comments

Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.

When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

Interest Rates

5/1 ARM+4.06%APR: +3.75%
30 Yr.
Fixed Mort.
+5.03%APR: +5.16%
$30K
HELOC
+8.00%APR: 0.00%
30 Mo
New Car Loan
+6.77%APR: 0.00%
1 Yr. CD+1.57%APR: +1.58%
DailyFinance Writers
Melly Alazraki Melly Alazraki Financial writer and analyst
James Altucher James Altucher Financial columnist
Jeff Bercovici Jeff Bercovici Media columnist
Jonathan Berr Jonathan Berr Financial writer and media columnist
Mercedes Cardona Mercedes Cardona Retail reporter
Tim Catts Tim Catts Financial writer
Peter Cohan Peter Cohan Author, venture capitalist and financial writer
Carrie Coolidge Carrie Coolidge Financial writer
Lita Epstein Lita Epstein Financial writer
Sam Gustin Sam Gustin Technology Writer
Nikhil Hutheesing Nikhil Hutheesing Tech and investing editor
Joseph Lazzaro Joseph Lazzaro Markets and economics writer
Latif Lewis Michelle Leder Financial Columnist
Latif Lewis Latif Lewis Business news editor and management columnist
Anthony Massucci Anthony Massucci Senior writer and tech columnist
Doug McIntyre Doug McIntyre Business and investing news writer and editor
Michael Mercurio Michael Mercurio Managing Editor
Todd Pruzan Todd Pruzan Features editor
Michael Rainey Michael Rainey Editor and economics writer
Alex Salkever Alex Salkever Senior technology writer
David Schepp David Schepp Business News reporter
Matthew Scott Matthew Scott Investing reporter and editor
Dan Solin Daniel R. Solin Author, investment advisor and retirement expert
Amey Stone Amey Stone Executive editor
Bruce Watson Mark Svenvold Columnist, renewable energy
Russel Turk, M.D. Russell Turk, M.D. Healthcare policy columnist
Bruce Watson Bruce Watson Features Writer
my portfolios

Find out why more people track their portfolios on AOL Money & Finance than anywhere else.

Create a New Portfolio My Portfolios

Daily Finance Partners

More from the Weblogs Network